TMCI

Treace Medical Concepts Stock Analysis

AI Rating

Low
  • Quality1/10
  • Growth 6/10
  • Momentum 0/10
Treace Medical Concepts sales and earnings growth
TMCI Growth
Good
  • Revenue Y/Y 7.90%
  • EPS Y/Y 19.19%
  • FCF Y/Y 39.01%
Treace Medical Concepts gross and profit margin trends
TMCI Profitability
Fair
  • Gross margin 79.90%
  • EPS margin -22.90%
  • ROIC -21.80%
Treace Medical Concepts net debt vs free cash flow
TMCI Risk
Great
  • Debt / Equity 0.7
  • Debt / FCF 2.2
  • Interest coverage -8.5

Treace Medical Concepts stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Medical Devices stocks ↗